bronchial asthma
Conditions
Interventions
Mometasone Furoate is administrated
Sponsors
Department of Respiratory Medicine and Allergology Kinki University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Sex:No object 2)Hospitalization or out patient:No object. 3)Aged>=15years old. 4)Mild-to-moderate persistent bronchial asthmatic patients by Asthma Prevention and Management Guideline 2009, Japan criteria. 5)A bronchial asthma patient controlled with a drug except the inhalation steroid medicine or the patient who was diagnosed as bronchial asthma newly. 6)The patient who was able to acquire an agreement by the document.(It is a document agreement by charges person consenting it about the minority)
Exclusion criteria
Exclusion criteria: 1)Patients with infections for which effective antibiotics do not exist and patients with invasive fungal infections. 2)a patient with the anamenesis of the erethism. 3)Patients with tuberculous disease. 4)Patients merges serious obstructive lung diseaseb sach sa chronic bronchitis, pneumonectasia or bronchiectasis. 5)Patients that a symptom by the fall of the adrenal system function is recognized 6Patients who cannot stop oral steroid all over current study period 7)During a pregnant woman, the nursing or a patient with possibility becoming pregnant. 8)Patients whom it was judged a doctor not to be suitable as an object of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IOS | — |
Secondary
| Measure | Time frame |
|---|---|
| Induced sputum test,exhaled NO,pulmonaryfunction(spirometry:FEV1.0,FEV1.0%,FVCandFEF25-75%) | — |
Countries
Japan
Contacts
Public ContactIwanaga,Takashi
Kinki University School of Medicine Respiratory medicine and allergology
Outcome results
None listed